Cagrilintide CAS 1415456-99-3 High quality GMP Certificated Weight Loss Peptides 5mg 10mg with 99% white Powder in Factory supply wholesale price CAS NO.1415456-99-3

1. We supply Peptides, APIs & Intermediates and so on to satisfy your needs;  
2. We will reply you for your inquiry in 24 hours;  
3. Strictly on selecting raw materials . Our Q&C team will inspect every product quality strictly before delivery;

4. Reasonable & competitive price, fast lead time ;

5. After delivery, we will track the products for you once every two days, until you get the products. When you got the goods, if you have any questions about the problem, contact with us, we will offer the solve way for you ;

6. 100% safe delivery, guaranteed delivery .

Cagrilintide   is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide, a GLP-1 receptor agonist, reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog and a GLP-1 receptor agonist appear to have an additive effect on appetite reduction. Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.